Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes: 2015-2024

Historic Other Working Capital Changes for Rhythm Pharmaceuticals (RYTM) over the last 10 years, with Dec 2024 value amounting to $5.5 million.

  • Rhythm Pharmaceuticals' Other Working Capital Changes fell 6123.58% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.3 million, marking a year-over-year increase of 271.92%. This contributed to the annual value of $5.5 million for FY2024, which is 292.07% up from last year.
  • According to the latest figures from FY2024, Rhythm Pharmaceuticals' Other Working Capital Changes is $5.5 million, which was up 292.07% from -$2.9 million recorded in FY2023.
  • In the past 5 years, Rhythm Pharmaceuticals' Other Working Capital Changes registered a high of $5.5 million during FY2024, and its lowest value of -$6.6 million during FY2022.
  • Over the past 3 years, Rhythm Pharmaceuticals' median Other Working Capital Changes value was -$2.9 million (recorded in 2023), while the average stood at -$1.3 million.
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Other Working Capital Changes skyrocketed by 705.99% in 2021, and later tumbled by 297.84% in 2022.
  • Over the past 5 years, Rhythm Pharmaceuticals' Other Working Capital Changes (Yearly) stood at -$551,000 in 2020, then surged by 705.99% to $3.3 million in 2021, then plummeted by 297.84% to -$6.6 million in 2022, then skyrocketed by 56.46% to -$2.9 million in 2023, then spiked by 292.07% to $5.5 million in 2024.